Grandview Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Grandview Asset Management's PFE Position: Q2 2025 in Review
Grandview Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 9,144 shares — an estimated $232K sold.
Grandview Asset Management first reported a position in PFE in Q4 2018 and held it in 18 quarters. The position peaked at $790K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Grandview Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Grandview Asset Management sold 9,144 Pfizer shares in Q2 2025, an estimated $232K.
- Grandview Asset Management first reported a position in Pfizer in Q4 2018 and held it in 18 quarters.
- Grandview Asset Management's Pfizer position peaked at $790K in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Grandview Asset Management's 13F filing for Q2 2025, filed 17 Jul 2025.